Antibody Glycosylation by Mass Spectrometry
通过质谱法进行抗体糖基化
基本信息
- 批准号:RGPIN-2017-05502
- 负责人:
- 金额:$ 2.04万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2018
- 资助国家:加拿大
- 起止时间:2018-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Antibodies (Abs) are glycoproteins of prime importance in the immune system, with immunoglobulin G (IgG) as their most common representative. There are many sources of IgGs and several motives to characterize their glycosylation patterns and amino acid (AA) sequences, which is the central theme of this proposal. The PI's laboratory has specialized in glycosylation analysis for over 20 years, and has trained many HQP. This proposal involves a minimum of 10 HQP over 5 years and each of them will benefit of interdisciplinary training in bioanalytical chemistry and mass spectrometry (MS). Sections of the proposal are summarized below.*******Part of IgG glycosylation occurs in the antigen-binding region (Fab domain) of the molecule, which varies from one type of IgG to the next with respect to AA sequence. As very little information is available in the literature about the variable portions of Fab domains, there is a strong need for the development of reliable methods and workflows to characterize the Fab with respect to glycosylation and AAs. This is important in order to learn more about Ab-antigen interactions and about the role of glycosylation in this process.*The IgGs will be from three sources: human plasma, swine plasma, and cell cultures from collaborators' laboratories.*******Human serum IgG is polyclonal, i.e. it has subtypes differing in their AA sequences (IgG1, IgG2, IgG3 and IgG4). Each subtype shows different levels affinity for specific receptors, but so far with MS it has been difficult to quantify these subtypes. It is proposed to develop a quantitative method which will use synthetic peptide standards unique to the sequence of each subtype. The ratios of these four subtypes has been found to vary slightly in the population, and this method will help investigate if immune system response may relate to these ratios.*******Also of interest are porcine IgGs. Differences in glycosylation between swine and human result in problems in the context of xenotransplantation (transplantation from animal to human). Normal pig organs are rejected by humans, and this is partly attributed to specific terminal sugars on the proteins. By knocking out (KO) the genes responsible for these, human-like organs and fluids may be generated for xenotransplantation. The objective is to fully characterize IgG glycosylation, in order to assess the efficiency of the KO process and understand the role of glycans in the rejection phenomena.*******IgG glycosylation analyses will be conducted using glycoproteomic approaches, for which novel capture-release methods (cleavable linkers) are presently being investigated in the PI's laboratory for their ability to capture glycopeptides and tested on monoclonal Abs from bioreactors. These new materials consist of linkers synthesized onto solid phase materials, e.g. functionalized silica or magnetic nanoparticles. These products will be of great interest to the glycoproteomics scientific community.******
抗体(Ab)是免疫系统中最重要的糖蛋白,免疫球蛋白G(IgG)是其最常见的代表。IgG有许多来源,并且有几种动机来表征其糖基化模式和氨基酸(AA)序列,这是本提案的中心主题。PI的实验室专门从事糖基化分析超过20年,并培养了许多HQP。该提案涉及至少10名HQP超过5年,他们每个人都将受益于生物分析化学和质谱(MS)的跨学科培训。提议各节摘要如下:**部分IgG糖基化发生在分子的抗原结合区(Fab结构域)中,就AA序列而言,不同类型的IgG的抗原结合区(Fab结构域)有所不同。由于文献中关于Fab结构域的可变部分的信息非常少,因此强烈需要开发可靠的方法和工作流程来表征Fab的糖基化和AA。这对于了解更多关于Ab-抗原相互作用以及糖基化在这一过程中的作用非常重要。* IgG将来自三个来源:人血浆、猪血浆和来自合作者实验室的细胞培养物。*人血清IgG是多克隆的,即其具有AA序列不同的亚型(IgG 1、IgG 2、IgG 3和IgG 4)。每种亚型对特定受体显示不同水平的亲和力,但到目前为止,MS很难量化这些亚型。建议开发一种定量方法,该方法将使用每种亚型序列特有的合成肽标准品。这四种亚型的比例在人群中略有不同,这种方法将有助于研究免疫系统反应是否与这些比例有关。还感兴趣的是猪IgG。猪和人之间糖基化的差异在异种移植(从动物移植到人)的情况下导致问题。正常的猪器官会被人类排斥,这部分归因于蛋白质上的特定末端糖。通过敲除(KO)负责这些的基因,可以产生用于异种移植的类人器官和体液。目的是全面表征IgG糖基化,以评估KO过程的效率并了解聚糖在排斥现象中的作用。*******将使用糖蛋白组学方法进行IgG糖基化分析,目前PI实验室正在研究新型捕获-释放方法(可切割接头)捕获糖肽的能力,并在生物反应器的单克隆抗体上进行检测。这些新材料由合成到固相材料上的连接剂组成,例如官能化二氧化硅或磁性纳米颗粒。这些产品将引起糖蛋白质组学科学界的极大兴趣。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Perreault, Helene其他文献
A systematic study of glycopeptide esterification for the semi-quantitative determination of sialylation in antibodies
- DOI:
10.1002/rcm.7287 - 发表时间:
2015-10-15 - 期刊:
- 影响因子:2
- 作者:
de Oliveira, Andrey Giovanni Gomes;Roy, Rini;Perreault, Helene - 通讯作者:
Perreault, Helene
On the use of DHB/aniline and DHB/N,N-dimethylaniline matrices for improved detection of carbohydrates:: Automated identification of oligosaccharides and quantitative analysis of sialylated glycans by MALDI-TOF mass spectrometry
- DOI:
10.1016/j.jasms.2008.04.033 - 发表时间:
2008-08-01 - 期刊:
- 影响因子:3.2
- 作者:
Snovida, Sergei I.;Rak-Banville, Justin M.;Perreault, Helene - 通讯作者:
Perreault, Helene
An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
- DOI:
10.3389/fonc.2023.1166207 - 发表时间:
2023 - 期刊:
- 影响因子:4.7
- 作者:
Teraiya, Milan;Perreault, Helene;Chen, Vincent C. - 通讯作者:
Chen, Vincent C.
N-Glycomic Changes in Human Breast Carcinoma MCF-7 and T-Lymphoblastoid Cells After Treatment with Herceptin and Herceptin/Lipoplex
- DOI:
10.1021/pr9010266 - 发表时间:
2010-03-01 - 期刊:
- 影响因子:4.4
- 作者:
Lattova, Erika;Tomanek, Boguslaw;Perreault, Helene - 通讯作者:
Perreault, Helene
Liquid chromatography-tandem mass spectrometry glycoproteomic study of porcine IgG and detection of subtypes
- DOI:
10.1002/rcm.9063 - 发表时间:
2021-05-15 - 期刊:
- 影响因子:2
- 作者:
Battellino, Taylor;Bacala, Raymond;Perreault, Helene - 通讯作者:
Perreault, Helene
Perreault, Helene的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Perreault, Helene', 18)}}的其他基金
Antibody Glycosylation by Mass Spectrometry
通过质谱法进行抗体糖基化
- 批准号:
RGPIN-2017-05502 - 财政年份:2019
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Antibody Glycosylation by Mass Spectrometry
通过质谱法进行抗体糖基化
- 批准号:
RGPIN-2017-05502 - 财政年份:2017
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
相似海外基金
Advancing Ultraviolet Photodissociation Mass Spectrometry for Precision Mapping of Protein Glycosylation
推进紫外光解离质谱技术以精确绘制蛋白质糖基化图谱
- 批准号:
10350600 - 财政年份:2021
- 资助金额:
$ 2.04万 - 项目类别:
Antibody Glycosylation by Mass Spectrometry
通过质谱法进行抗体糖基化
- 批准号:
RGPIN-2017-05502 - 财政年份:2021
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Antibody Glycosylation by Mass Spectrometry
通过质谱法进行抗体糖基化
- 批准号:
RGPIN-2017-05502 - 财政年份:2020
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Antibody Glycosylation by Mass Spectrometry
通过质谱法进行抗体糖基化
- 批准号:
RGPIN-2017-05502 - 财政年份:2019
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Antibody Glycosylation by Mass Spectrometry
通过质谱法进行抗体糖基化
- 批准号:
RGPIN-2017-05502 - 财政年份:2017
- 资助金额:
$ 2.04万 - 项目类别:
Discovery Grants Program - Individual
Development of a rapid glycosylation profiling system using mass spec data
使用质谱数据开发快速糖基化分析系统
- 批准号:
8326733 - 财政年份:2009
- 资助金额:
$ 2.04万 - 项目类别:
Studying HIV gp120 Glycosylation with Mass Spectrometry
利用质谱法研究 HIV gp120 糖基化
- 批准号:
7686515 - 财政年份:2009
- 资助金额:
$ 2.04万 - 项目类别:
Development of a rapid glycosylation profiling system using mass spectrometry dat
使用质谱数据开发快速糖基化分析系统
- 批准号:
9096849 - 财政年份:2009
- 资助金额:
$ 2.04万 - 项目类别:
Studying HIV gp120 Glycosylation with Mass Spectrometry
利用质谱法研究 HIV gp120 糖基化
- 批准号:
7849929 - 财政年份:2009
- 资助金额:
$ 2.04万 - 项目类别:
Development of a rapid glycosylation profiling system using mass spec data
使用质谱数据开发快速糖基化分析系统
- 批准号:
7695559 - 财政年份:2009
- 资助金额:
$ 2.04万 - 项目类别: